% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zimmer:162850,
author = {Zimmer, Till S and David, Bastian and Broekaart, Diede W M
and Schidlowski, Martin and Ruffolo, Gabriele and Korotkov,
Anatoly and van der Wel, Nicole N and van Rijen, Peter C and
Mühlebner, Angelika and van Hecke, Wim and Baayen, Johannes
C and Idema, Sander and François, Liesbeth and van Eyll,
Jonathan and Dedeurwaerdere, Stefanie and Kessels, Helmut W
and Surges, Rainer and Rüber, Theodor and Gorter, Jan A and
Mills, James D and van Vliet, Erwin A and Aronica, Eleonora},
title = {{S}eizure-mediated iron accumulation and dysregulated iron
metabolism after status epilepticus and in temporal lobe
epilepsy.},
journal = {Acta neuropathologica},
volume = {142},
number = {4},
issn = {1432-0533},
address = {Heidelberg},
publisher = {Springer},
reportid = {DZNE-2021-01505},
pages = {729 - 759},
year = {2021},
abstract = {Neuronal dysfunction due to iron accumulation in
conjunction with reactive oxygen species (ROS) could
represent an important, yet underappreciated, component of
the epileptogenic process. However, to date, alterations in
iron metabolism in the epileptogenic brain have not been
addressed in detail. Iron-related neuropathology and
antioxidant metabolic processes were investigated in
resected brain tissue from patients with temporal lobe
epilepsy and hippocampal sclerosis (TLE-HS), post-mortem
brain tissue from patients who died after status epilepticus
(SE) as well as brain tissue from the electrically induced
SE rat model of TLE. Magnetic susceptibility of the presumed
seizure-onset zone from three patients with focal epilepsy
was compared during and after seizure activity. Finally, the
cellular effects of iron overload were studied in vitro
using an acute mouse hippocampal slice preparation and
cultured human fetal astrocytes. While iron-accumulating
neurons had a pyknotic morphology, astrocytes appeared to
acquire iron-sequestrating capacity as indicated by
prominent ferritin expression and iron retention in the
hippocampus of patients with SE or TLE. Interictal to
postictal comparison revealed increased magnetic
susceptibility in the seizure-onset zone of epilepsy
patients. Post-SE rats had consistently higher hippocampal
iron levels during the acute and chronic phase (when
spontaneous recurrent seizures are evident). In vitro, in
acute slices that were exposed to iron, neurons readily took
up iron, which was exacerbated by induced epileptiform
activity. Human astrocyte cultures challenged with iron and
ROS increased their antioxidant and iron-binding capacity,
but simultaneously developed a pro-inflammatory phenotype
upon chronic exposure. These data suggest that
seizure-mediated, chronic neuronal iron uptake might play a
role in neuronal dysfunction/loss in TLE-HS. On the other
hand, astrocytes sequester iron, specifically in chronic
epilepsy. This function might transform astrocytes into a
highly resistant, pro-inflammatory phenotype potentially
contributing to pro-epileptogenic inflammatory processes.},
keywords = {Adult / Aged / Aged, 80 and over / Animals / Astrocytes:
metabolism / Astrocytes: pathology / Case-Control Studies /
Cell Culture Techniques / Disease Models, Animal / Epilepsy,
Temporal Lobe: complications / Epilepsy, Temporal Lobe:
metabolism / Epilepsy, Temporal Lobe: pathology / Female /
Hippocampus: metabolism / Humans / Iron: metabolism / Iron
Metabolism Disorders: etiology / Iron Metabolism Disorders:
pathology / Male / Middle Aged / Oxidative Stress:
physiology / Rats / Status Epilepticus: complications /
Status Epilepticus: metabolism / Status Epilepticus:
pathology / Astrocytes (Other) / Glutathione metabolism
(Other) / Iron (Other) / Status epilepticus (Other) /
Temporal lobe epilepsy with hippocampal sclerosis (Other)},
cin = {AG Stöcker},
ddc = {610},
cid = {I:(DE-2719)1013026},
pnm = {354 - Disease Prevention and Healthy Aging (POF4-354)},
pid = {G:(DE-HGF)POF4-354},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34292399},
pmc = {pmc:PMC8423709},
doi = {10.1007/s00401-021-02348-6},
url = {https://pub.dzne.de/record/162850},
}